Terms: = Sarcomas AND COL1A1, P02452, 1277, ENSG00000108821, OI4
179 results:
1. Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.
Ono T; Noguchi R; Osaki J; Akiyama T; Adachi Y; Kojima N; Toda Y; Fukushima S; Yoshimatsu Y; Yoshida A; Kawai A; Kondo T
Hum Cell; 2024 May; 37(3):854-864. PubMed ID: 38372888
[TBL] [Abstract] [Full Text] [Related]
2. col1a1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
[TBL] [Abstract] [Full Text] [Related]
3. hsa_circ_0020378 regulating miR-339-3p/col1a1 promotes osteosarcoma progression.
Liu L; Huang W
Cancer Biol Ther; 2023 Dec; 24(1):2274120. PubMed ID: 37978903
[TBL] [Abstract] [Full Text] [Related]
4. col1a1::PDGFB fusion uterine sarcoma with a TERT promoter mutation.
Lu Y; Chen X; Zeng W; Hua P; Shen Y; Qiu Y; He X; Zhang H
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23210. PubMed ID: 37870859
[TBL] [Abstract] [Full Text] [Related]
5. col1a1-PDGFB Fusion Gene Detection Through Bulk RNA-Seq and Transcriptomic Features of Dermatofibrosarcoma Protuberans.
Peng R; Zhang G; Li H
Dermatol Surg; 2023 May; 49(5S):S27-S33. PubMed ID: 37115997
[TBL] [Abstract] [Full Text] [Related]
6. Platelet-Derived Growth Factor-D Fusion-Positive Dermatofibrosarcoma Protuberans: Case Report of an Atypical Breast Mass and Literature Review.
Chandler B; Jing F; David MP; Nazarullah A
Int J Surg Pathol; 2023 Dec; 31(8):1610-1617. PubMed ID: 37016743
[TBL] [Abstract] [Full Text] [Related]
7. Establishing an RNA fusions panel in soft tissue sarcoma with clinical validation.
Huang X; Li G; Li L; Wang J; Shen J; Chen Y; Yu W; Chen A; Wu T; Ma J; Ling B; He L; Chen X
Sci Rep; 2023 Mar; 13(1):4403. PubMed ID: 36928336
[TBL] [Abstract] [Full Text] [Related]
8. col1a1-PDGFB Fusion Associated Fibrosarcoma of the Uterine Corpus: A Case Report and Literature Review.
Panwar V; Liu Y; Gwin K; Chen H
Int J Gynecol Pathol; 2023 Mar; 42(2):143-146. PubMed ID: 36729934
[TBL] [Abstract] [Full Text] [Related]
9. Review of dermatofibrosarcoma protuberans.
Lim SX; Ramaiya A; Levell NJ; Venables ZC
Clin Exp Dermatol; 2023 Mar; 48(4):297-302. PubMed ID: 36630365
[TBL] [Abstract] [Full Text] [Related]
10. [Cryptic col1a1-PDGFB fusion in dermatofibrosarcoma protuberans: a clinicopathological and genetic analysis].
Chen M; Chen YM; Lu Y; He X; Peng H; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2023 Jan; 52(1):13-18. PubMed ID: 36617900
[No Abstract] [Full Text] [Related]
11. Dermatofibrosarcoma protuberans of the face: A clinicopathologic and molecular study of 34 cases.
Han Q; Chen M; Yang J; Du T; Peng H
J Dtsch Dermatol Ges; 2022 Nov; 20(11):1463-1473. PubMed ID: 36377270
[TBL] [Abstract] [Full Text] [Related]
12. Giant cell fibroblastoma: a case report.
Hrudka J; Hojný J; Leamerová E; Matěj R
Cesk Patol; 2022; 58(3):161-165. PubMed ID: 36224038
[TBL] [Abstract] [Full Text] [Related]
13. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
[TBL] [Abstract] [Full Text] [Related]
14. Successful treatment of metastatic fibrosarcomatous dermatofibrosarcoma protuberans with imatinib mesylate.
Kambayashi Y; Kasahara Y; Ohuchi K; Amagai R; Hashimoto A; Asano Y; Fujimura T
Dermatol Ther; 2022 Oct; 35(10):e15736. PubMed ID: 35898161
[TBL] [Abstract] [Full Text] [Related]
15. Update on Mesenchymal Lesions of the Lower Female Genital Tract.
Croce S; Perret R; Le Loarer F
Surg Pathol Clin; 2022 Jun; 15(2):341-367. PubMed ID: 35715165
[TBL] [Abstract] [Full Text] [Related]
16. [Clinicopathological characteristics and molecular alterations of primary cardiac leiomyosarcoma: report of five cases].
Dong F; Chen D; Shang JF; Fang W; Han LY; Lian GL; Wang H; Zheng MH
Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):512-517. PubMed ID: 35673722
[No Abstract] [Full Text] [Related]
17. Dermatofibrosarcoma protuberans with unusual presentation in vulva.
Barrios Barreto R; Mendoza Suarez L; Del Valle A; Silvera Redondo C; De La Hoz Pabola A
Medicina (B Aires); 2022; 82(3):441-444. PubMed ID: 35639067
[TBL] [Abstract] [Full Text] [Related]
18. Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing's Sarcoma Using Bioinformatics Analysis.
Zhang J; Huang J; Liu W; Ding L; Cheng D; Xiao H
J Immunol Res; 2022; 2022():3655908. PubMed ID: 35578666
[TBL] [Abstract] [Full Text] [Related]
19. A Case of col1a1-PDGFB Fusion Uterine Sarcoma.
Hogeboom A; Bárcena C; Parrilla-Rubio L; Revilla E; Ruano Y; Gallego-Gutiérrez I; Martínez-López M
Int J Gynecol Pathol; 2023 Mar; 42(2):147-150. PubMed ID: 35551153
[TBL] [Abstract] [Full Text] [Related]
20. Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.
Peng C; Jian X; Xie Y; Li L; Ouyang J; Tang L; Zhang X; Su J; Zhao S; Liu H; Yin M; Wu D; Wan M; Xie L; Chen X
Br J Dermatol; 2022 Jun; 186(6):997-1009. PubMed ID: 35441365
[TBL] [Abstract] [Full Text] [Related]
[Next]
